ESMO 2023 brings together researchers, clinicians, scientists and healthcare market leaders from all over the world.
The congress hosts the latest cutting-edge data, high-quality education, and innovations on the field.
Accelsiors is deeply involved in the field of oncology (breast, ovarian, renal cancer, melanoma etc), and our team has designed and executed numerous trials in the past two decades with an excellent record of accomplishment.
We are a targeted CRO with extensive experience in oncology trials and all the regulatory pathways around them. For the past 20 years our team has designed and executed numerous Phase I-III studies in oncology with targeting therapies such as small molecules, biosimilars, pegylated filgrastim, vaccines and monoclonal antibodies. Having access to patients with rare biomarkers, we can conduct state-of-the-art basket, umbrella, and adaptive trials.
Contact us to arrange an appointment to meet our representatives in Madrid to share our experiences, interact and discuss the latest developments in medical oncology.
